Requests Senate Committee on Insurance to study health insurance issuers providing coverage of medications for sexual performance enhancement.
Impact
This resolution reflects a growing need to understand the implications of health insurance coverage for sexual performance medications within the state. By requesting a comprehensive study, the resolution aims to gather data and recommendations that could inform future legislative actions. It acknowledges the landscape of healthcare coverage where, since 2006, federal funds are not permitted to cover these medications under programs like Medicaid and Medicare, influencing the decisions of various state insurance programs to eliminate coverage for these drugs.
Summary
Senate Resolution No. 150, introduced by Senator Peterson, urges the Senate Committee on Insurance to study health insurance coverage policies for medications related to sexual performance enhancement. The resolution comes in light of recent legislative discussions and actions concerning whether health insurance providers in Louisiana should be mandated, prohibited, or allowed to include coverage for such medications, including both pioneer and generic drugs like Viagra. The bill highlights an ongoing examination of healthcare policies regarding coverage for specific medications that have faced scrutiny at state and federal levels alike.
Sentiment
The sentiment surrounding SR150 appears to be focused on the necessity for informed legislative action rather than outright opposition or support for a specific policy. The request for a study demonstrates a desire for a thorough understanding that will cater to the diverse needs of constituents. This approach indicates a level of caution in addressing a potentially sensitive issue while ensuring that legislation is grounded in research and data, thereby reducing partisan divides.
Contention
One notable point of contention that may arise from this study request pertains to the broader implications of health insurance coverage. Discussions could center around whether covering such medications is a matter of personal health and rights or should be subject to limitations by insurance providers. Additionally, examining the financial impacts on both insurance companies and consumers could trigger debates regarding the ethical and practical considerations of healthcare coverage for medications that enhance sexual performance, which some may view as non-essential.
Requests the House and Senate insurance committees to study requiring health insurance coverage of an annual screening for sexually transmitted diseases
Requests the House and Senate committees on insurance to study termination or cancellation of health and accident insurance coverage by insurers and health maintenance organizations
Requests the Department of Insurance to study and issue a report relative to the impact of health insurance coverage mandates on the cost of health insurance
Requests the Department of Insurance to create a task force to study the causes of infertility in women and mandating insurance coverage of fertility treatments for women.
Requests the Department of Insurance to create a task force to study the causes of infertility in women and mandating insurance coverage of fertility treatments for women.